Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Seeks to Become A ‘Global Presence’

Sees opportunities for legalized marijuana marketing in Canada, Germany, all of Western Europe and South America Armed with $43 million in working capital, it sees advantages for itself in product and financing It has a proprietary process in its indoor growing environment to control temperature, humidity and water to produce standardized, pesticide-free cannabis ABcann Global […]

Pressure BioSciences, Inc. (PBIO) Game-Changing Pressure Cycling Technology Is Revolutionizing Scientific Research at the Most Fundamental Level

Company is positioned to disrupt the $6 billion global life sciences sample preparation market Pressure Cycling Technology (PCT) is a game-changer in bolstering the quality and efficacy of scientific research Next generation Barocycler 2320EXTREME instrument is becoming a crucial research tool in “Cancer Moonshot” laboratories and has been named a finalist in the prestigious 2017 […]

India Globalization Capital, Inc. (NYSE: IGC) Could Release Potential Blockbuster Alzheimer’s Treatment in Early 2018

On the verge of releasing potential Cannabis-based blockbuster Alzheimer’s treatment Company is able to hugely accelerate release of this treatment in recreational cannabis states Market potential for drugs to treat and prevent Alzheimer’s is in the billions of dollars According to information from the Alzheimer’s Association, approximately 47 million people are living with dementia throughout […]

$230 Million ICO on the Rocks

A recent Reuters special report on an imperiled cryptocurrency venture shines a harsh light on some of the many risks and the paucity of regulatory oversight in cryptocurrencies and Initial Coin Offerings (ICOs) (http://dtn.fm/Jvc7A). Cryptocurrencies are digital mediums of exchange that function through extremely complex code systems called blockchain technology that encrypt sensitive data transfers, […]

Grey Cloak Tech Inc. (GRCK) is “One to Watch”

Eqova Life Sciences subsidiary serves underserved market in booming CBD sector Clinical-grade, full-spectrum hemp oil products specifically produced for licensed medical use CBD market expected to grow 700% to $2.1 billion by 2020 Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned […]

Recent News Highlights the Growing Market for Patriot One Technologies, Inc.’s (TSX.V: PAT) (OTCQB: PTOTF) High Technology Device

Company’s PATSCAN™ Cognitive Microwave Radar (CMR) detects concealed weapons and identifies new threats Report: Airport security market $9 billion in 2016, projected compound annual growth rate (CAGR) of 7%, 2016–2024 Martin Cronin, CEO, calls technology “game changing” in deterring violence before it happens Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) offers technology that can […]

Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021

Owns patented Invisicare® polymer delivery system, prescription and over-the-counter skincare products formulated with Invisicare Business model to grow globally by out-licensing its proprietary and patented product line Developed multiple cannabis-based products with CBD from imported hemp (non-psychoactive), and will continue to develop line utilizing CBD and THC from marijuana Skinvisible, Inc. (OTCQB: SKVI) is targeting […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

February 2, 2026

Cutaneous T-cell lymphoma (“CTCL”) remains a cancer with limited treatment options, persistent symptoms and long-term quality-of-life challenges for patients, even decades after its classification as a distinct disease. Despite medical advances in oncology, many people living with CTCL continue to cycle through therapies that offer only partial relief or introduce new burdens. Soligenix (NASDAQ: SNGX) […]

Rotate your device 90° to view site.